2-amino-5-phosphonovalerate has been researched along with alpha-synuclein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, J; Castanho, MA; Dias, RB; Diógenes, MJ; Franquelim, HG; Guerreiro, P; Ingelsson, M; Lannfelt, L; Lopes, LV; Maiolino, F; Näsström, T; Oliveira, LM; Outeiro, TF; Quintas, A; Rombo, DM; Sebastião, AM; Vicente Miranda, H | 1 |
1 other study(ies) available for 2-amino-5-phosphonovalerate and alpha-synuclein
| Article | Year |
|---|---|
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Synuclein; Animals; Biophysics; Biotinylation; Cell Line, Tumor; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Extracellular Fluid; Hippocampus; Humans; Insulin; L-Lactate Dehydrogenase; Long-Term Potentiation; Male; Neuroblastoma; Organ Culture Techniques; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission; Valine | 2012 |